logo
Cases
Home > Cases > Beijing Anrate Biotechnology Co., Ltd. latest company case about A Comparative Study Between Recombinant Human Serum Albumin (rHSA) and Blood‑Derived Human Serum Albumin (HSA)
Events
CONTACT US

A Comparative Study Between Recombinant Human Serum Albumin (rHSA) and Blood‑Derived Human Serum Albumin (HSA)

2026-05-12

latest company news about A Comparative Study Between Recombinant Human Serum Albumin (rHSA) and Blood‑Derived Human Serum Albumin (HSA)

A Study on the Effects on Proliferation of Peripheral Blood Mononuclear Cells (PBMCs)


Test Cells: Human Peripheral Blood Mononuclear Cells (PBMCs)
Test System: Lymphocyte Expansion Medium


latest company case about [#aname#]

Conclusion:
1.The expansion efficacy of defatted recombinant human serum albumin (rHSA) is inferior to that of plasma‑derived human serum albumin (HSA).

2.Upon conjugation with specific fatty acids, rHSA shows better expansion efficacy than plasma‑derived human serum albumin (HSA).


Study on the Effects on Stem Cell Growth and Stemness Maintenance


Test Cells: Human Induced Pluripotent Stem Cells (iPSCs)
Test System: Pluripotent Stem Cell Expansion Medium


latest company case about [#aname#]


Conclusion:
1.The expansion performance of defatted recombinant human serum albumin (rHSA) is superior to that of plasma‑derived human serum albumin (HSA).
2.Cells cultured with plasma‑derived HSA show morphological changes and tend to undergo premature differentiation, while defatted rHSA contributes to stemness maintenance.

Important Notice

This product is intended solely for scientific research, laboratory and production purposes. It is not for clinical treatment and shall not be used on animals or humans.

Feel free to contact us

WhatsApp: +85363312841 | Email: sales@bjanrate.cn

Send your inquiry directly to us

Privacy Policy China Good Quality Recombinant Human Albumin Supplier. Copyright © 2026 Beijing Anrate Biotechnology Co., Ltd. . All Rights Reserved.